ESCA

ESCA Total Assets

$234.52MQuarterly · USD

Period ending:

ESCA FY Total AssetsUSD
ESCA FY Total Assets1985-12-31: $20.50M1986-12-31: $27.30M1987-12-31: $36.30M1988-12-31: $37.70M1989-12-31: $58.70M1990-12-31: $55.20M1991-12-31: $54.80M1992-12-31: $60.50M1993-12-31: $66.10M1994-12-31: $75.90M1995-12-31: $57.80M1996-12-31: $54.40M1997-12-31: $66.10M1998-12-31: $63.50M1999-12-31: $66.80M2000-12-31: $69.48M2001-12-31: $76.11M2002-12-31: $96.79M2003-12-31: $134.44M2004-12-31: $135.10M2005-12-31: $125.30M2006-12-31: $150.72M2007-12-31: $152.02M2008-12-31: $147.70M2009-12-31: $127.24M2010-12-31: $127.55M2011-12-31: $130.12M2012-12-31: $125.74M2013-12-31: $141.97M2014-12-31: $127.88M2015-12-31: $143.74M2016-12-31: $150.76M2017-12-31: $156.11M2018-12-31: $149.53M2019-12-31: $148.78M2020-12-31: $220.71M2021-12-31: $251.80M2022-12-31: $298.72M2023-12-31: $253.01M2024-12-31: $226.33M2025-12-31: $222.11M$298.72M$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

ESCA total assets history

Total value of everything the company owns. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Escalade Inc Total Assets — Annual fiscal periods (USD)
Period endingTotal Assets (USD)
222,109,000
226,330,000
253,005,000
298,718,000
251,798,000
220,705,000
148,779,000
149,527,000
156,105,000
150,761,000
143,737,000
127,881,000
141,974,000
125,740,000
130,115,000
127,553,000
127,238,000
147,701,000
152,016,000
150,715,000
125,296,000
135,099,000
134,437,000
96,788,142
76,111,000
69,475,745
66,800,000
63,500,000
66,100,000
54,400,000
57,800,000
75,900,000
66,100,000
60,500,000
54,800,000
55,200,000
58,700,000
37,700,000
36,300,000
27,300,000
20,500,000

Compare total assets

All ESCA financial metrics · ESCA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.